Aduro biotech, inc. (ADRO)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Revenue:
Total revenue

17,258

15,087

17,239

50,681

-

-

-

Collaboration and license revenue

-

-

-

-

71,689

13,038

-

Grant revenue

-

-

-

-

1,290

351

828

Total revenue

-

-

-

-

72,979

13,389

828

Operating expenses:
Research and development

67,045

75,836

89,382

87,718

58,649

23,513

10,687

General and administrative

34,795

36,035

33,751

34,277

27,805

8,994

4,677

Loss on impairment of intangible assets

5,006

3,992

-

-

-

-

-

Amortization of intangible assets

554

584

559

549

89

0

0

Total operating expenses

107,400

116,447

123,692

122,544

86,543

32,507

15,364

Loss from operations

-90,142

-101,360

-106,453

-71,863

-13,564

-19,118

-14,536

Loss from remeasurement of fair value of warrants

-

-

-

-

26,077

566

162

Interest income

5,451

5,284

3,444

2,219

494

-

-

Gain on extinguishment of convertible promissory notes

-

-

-

-

-

3,553

-

Interest income, net

-

-

-

-

-

-2,395

-1,371

Other expense, net

-93

-64

-218

-40

-161

1,512

15

Loss before income tax

-84,784

-96,140

-103,227

-69,684

-39,308

-17,014

-16,054

Income tax benefit

-2,412

-783

-11,364

21,464

-99

-

-

Net loss

-82,372

-95,357

-91,863

-91,148

-39,209

-17,014

-16,054

Net loss per common share, basic and diluted

-1.03

-1.21

-1.26

-1.40

-0.88

-53.06

-55.80

Shares used in computing net loss per common share, basic and diluted

80,110

78,812

72,901

65,200

44,706

320

287

Collaboration and license revenue
Total revenue

17,258

15,087

17,109

50,593

-

-

-

Grant revenue
Total revenue

-

-

130

88

-

-

-